doi: 10.1007/s11154-022-09735-8
Only 10% said they would make no trade-offs at all
[6] Tirzepatide (Mounjaro): up to 15 mg once weekly for type 2 diabetes, and up to 15 mg once weekly for chronic weight management (marketed as Tirzepatide)
- UCHealth, accessed April 22, 2025, What is the MOA for GLP-1 drugs and how do they work?, accessed April 22, 2025, Transform Your Health: The Power of GLP-1 Injections for Effective Weight Loss, accessed April 22, 2025, Glucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI Bookshelf, accessed April 22, 2025, Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS in, accessed April 22, 2025, How GLP-1 Medications Affect Appetite | Big Tree Medical Weight Loss, accessed April 22, 2025, Effects of GLP-1 on appetite and weight - PMC - PubMed Central, accessed April 22, 2025, 19 Semaglutide (Ozempic, Wegovy) Side Effects You Should Know About - GoodRx, accessed April 22, 2025, Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists - PubMed, accessed April 22, 2025, Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period
The GLP-1 receptor agonists approved for weight loss include: Zepbound (tirzepatide), Saxenda (liraglutide), and Wegovy (semaglutide)
The full timeline for GLP-1 to start working depends on your specific formulation, dose, and individual metabolism
